# OnCo record mitoxantrone (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mitoxantrone/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mitoxantrone" ;
  schema:name "Mitoxantrone"@en ;
  schema:description "Mitoxantrone is a blue chemotherapy infusion used with cytarabine for acute myeloid leukaemia and, historically, to relieve pain in advanced prostate cancer; it is also licensed for multiple sclerosis."@en ;
  schema:url <https://onco.cc/drugs/mitoxantrone/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mitoxantrone> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mitoxantrone>, <https://www.cancer.gov/about-cancer/treatment/drugs/mitoxantronehydrochloride> ;
  onco:status "approved" ;
  onco:tag "nci-list", "generic" ;
  onco:modality "Anthracenedione (topoisomerase II inhibitor)" ;
  schema:alternateName "Novantrone (historic)" ;
  onco:approval "US 1987: Acute non-lymphocytic leukaemia in adults (combination); later hormone-refractory prostate cancer pain (with corticosteroids) and multiple sclerosis" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:trials <https://onco.cc/trials/nct03591510/>, <https://onco.cc/trials/nct04668690/>, <https://onco.cc/trials/nct03182244/> .